Klin Padiatr 2022; 234(05): 339
DOI: 10.1055/s-0042-1754501
Abstracts
Poster
Poster Walk 4: CF

Measuring CFTR func Meissner tion in respiratory epithelial cell cultures: step to individualize treatments in cystic fibrosis?

J Große-Onnebrink
1   University Hospital Muenster, Pediatric Pneumology / General Pediatrics, Muenster, Germany
,
H Omran
1   University Hospital Muenster, Pediatric Pneumology / General Pediatrics, Muenster, Germany
,
V Mete
1   University Hospital Muenster, Pediatric Pneumology / General Pediatrics, Muenster, Germany
,
WM Weber
1   University Hospital Muenster, Pediatric Pneumology / General Pediatrics, Muenster, Germany
› Institutsangaben
 

Introduction Cystic fibrosis (CF) is caused by CFTR-dysfunction. We present a method to measure CFTR-function in respiratory epithelial cells (REC).

Methods We derived REC from nasal brushings in CF patients and controls and processed them to air liquid interface (ALI) cultures. We measured transepithelial conductance with an ussing chamber. Change in conductance (ΔcAMP mS) is reported after applying cAMP and after introducing wtCFTR-mRNA to the cell layer with chitosan-based nanocapsules as a vector.

Results We performed 43 measurements in 9 patients with CF and 32 measurements in 8 controls. Median change in ΔcAMP was 0.78 (min: 0.41; max: 1.34) mS in controls and 0.03 (0.75; 0.29) in CF patients (p<0.000). We propose a threshold of 0.3 ΔcAMP mS to discriminate CF from non-CF epithelia. We transfected REC of 6 CF patients (n=26 measurements) with wtCFTR-mRNA. Median ΔcAMP was 0.81 (0.10; 1.77) in controls and 0.03 (-0.93; 0.29) in CF at baseline and 0.83 (0.37; 1.88) 0.43 (-0.02; 1.19), 0.18 (0.07; 0.21) at 24, 48 and 72 hours (h) after transfection with wtCFTR-mRNA in CF patients. Median ΔcAMP at baseline and after 24h and 48h but not after 72h were significantly different.

Conclusions Conductance measurements in ALI cultures from nasal brushings in CF patients is feasible and assesses CFTR function. Measurements discriminate CF from non-CF patients and show a treatment response after transfection with wtCFTR. The method may be an additional diagnostic tool to measure CFTR function, is a promising method for testing substances for CFTR restoration and may guide future individualized CFTR-modulator therapy in CF.



Publikationsverlauf

Artikel online veröffentlicht:
21. September 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany